Alterations in serum sodium in relation to atrial natriuretic factor and other neuroendocrine variables in experimental pacing-induced heart failure

Department of Medicine, St. Michael's Hospital, University of Toronto, Ontario, Canada.

The pathophysiologic role of atrial natriuretic factor and other neuroendocrine variables in relation to serum sodium and renal function was evaluated in 15 conscious dogs with severe chronic ventricular pacing-induced heart failure (250 beats/min for 5.1 +/- 0.4 weeks). Six sham-operated dogs observed over an 8 week period served as controls. Development of heart failure was characterized by a progressive increase in plasma norepinephrine, renin activity and aldosterone from control values of 293 +/- 15 pg/ml, 1.4 +/- 0.4 ng/ml per h and 124 +/- 42 pg/ml, respectively, to 1,066 +/- 96 pg/ml, 10.2 +/- 2.4 ng/ml per h and 577 +/- 151 pg/ml (all p less than 0.01), respectively, at severe heart failure. In contrast to other neuroendocrine variables, plasma atrial natriuretic factor increased from a control level of 243 +/- 74 pg/ml to a peak concentration of 724 +/- 149 pg/ml (p less than 0.01) at 2 weeks, then declined and plateaued at twice the level of the control value as severe heart failure developed. At severe heart failure, serum sodium decreased from 147 +/- 0.6 to 141.8 +/- 2.1 mmol/liter (p less than 0.05), whereas urea increased from 6.0 +/- 0.5 to 7.8 +/- 0.6 mmol/liter (p less than 0.05). The change in serum sodium concentration correlated with plasma renin activity and aldosterone (r = -0.77, -0.88, respectively, both p less than 0.01), but not with norepinephrine or atrial natriuretic factor. When sinus rhythm was restored, 14 dogs were observed for 48 to 72 h and 8 dogs were followed up for another 4 weeks after cessation of pacing.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				A. Khan, G. W. Moe, N. Nili, E. Rezaei, M. Eskandarian, J. Butany, and B. H. Strauss The cardiac atria are chambers of active remodeling and dynamic collagen turnover during evolving heart failure J. Am. Coll. Cardiol., January 7, 2004; 43(1): 68 - 76. [Abstract] [Full Text] [PDF]

				K. Shinagawa, Y.-F. Shi, J.-C. Tardif, T.-K. Leung, and S. Nattel Dynamic Nature of Atrial Fibrillation Substrate During Development and Reversal of Heart Failure in Dogs Circulation, June 4, 2002; 105(22): 2672 - 2678. [Abstract] [Full Text] [PDF]

				D. B Haitsma, D. Bac, N. Raja, F. Boomsma, P. D Verdouw, and D. J Duncker Minimal impairment of myocardial blood flow responses to exercise in the remodeled left ventricle early after myocardial infarction, despite significant hemodynamic and neurohumoral alterations Cardiovasc Res, December 1, 2001; 52(3): 417 - 428. [Abstract] [Full Text] [PDF]

				T. Hisaoka, M. Yano, T. Ohkusa, M. Suetsugu, K. Ono, M. Kohno, J. Yamada, S. Kobayashi, M. Kohno, and M. Matsuzaki Enhancement of Rho/Rho-kinase system in regulation of vascular smooth muscle contraction in tachycardia-induced heart failure Cardiovasc Res, February 1, 2001; 49(2): 319 - 329. [Abstract] [Full Text] [PDF]

				K. Ono, M. Yano, T. Ohkusa, M. Kohno, T. Hisaoka, T. Tanigawa, S. Kobayashi, M. Kohno, and M. Matsuzaki Altered interaction of FKBP12.6 with ryanodine receptor as a cause of abnormal Ca2+ release in heart failure Cardiovasc Res, November 1, 2000; 48(2): 323 - 331. [Abstract] [Full Text] [PDF]

				T. Tanigawa, M. Yano, M. Kohno, T. Yamamoto, T. Hisaoka, K. Ono, T. Ueyama, S. Kobayashi, Y. Hisamatsu, T. Ohkusa, et al. Mechanism of preserved positive lusitropy by cAMP-dependent drugs in heart failure Am J Physiol Heart Circ Physiol, February 1, 2000; 278(2): H313 - H320. [Abstract] [Full Text] [PDF]

				T. Yamamoto, M. Yano, M. Kohno, T. Hisaoka, K. Ono, T. Tanigawa, Y. Saiki, Y. Hisamatsu, T. Ohkusa, and M. Matsuzaki Abnormal Ca2+ release from cardiac sarcoplasmic reticulum in tachycardia-induced heart failure Cardiovasc Res, October 1, 1999; 44(1): 146 - 155. [Abstract] [Full Text] [PDF]

				G. W Moe and P. Armstrong Pacing-induced heart failure: a model to study the mechanism of disease progression and novel therapy in heart failure Cardiovasc Res, June 1, 1999; 42(3): 591 - 599. [Full Text] [PDF]

				M. A. Vos, S. H. M. de Groot, S. C. Verduyn, J. van der Zande, H. D. M. Leunissen, J. P. M. Cleutjens, M. van Bilsen, M. J. A. P. Daemen, J. J. Schreuder, M. A. Allessie, et al. Enhanced Susceptibility for Acquired Torsade de Pointes Arrhythmias in the Dog With Chronic, Complete AV Block Is Related to Cardiac Hypertrophy and Electrical Remodeling Circulation, September 15, 1998; 98(11): 1125 - 1135. [Abstract] [Full Text] [PDF]

				G. W Moe, A. Albernaz, G. O Naik, M. Kirchengast, and D. J Stewart Beneficial effects of long-term selective endothelin type A receptor blockade in canine experimental heart failure Cardiovasc Res, September 1, 1998; 39(3): 571 - 579. [Abstract] [Full Text] [PDF]

				H. Ishise, H. Asanoi, S. Ishizaka, S. Joho, T. Kameyama, K. Umeno, and H. Inoue Time course of sympathovagal imbalance and left ventricular dysfunction in conscious dogs with heart failure J Appl Physiol, April 1, 1998; 84(4): 1234 - 1241. [Abstract] [Full Text] [PDF]

				R. P. Shannon, S. Friedrich, M. Mathier, and D. R. Knight Effects of renin inhibition compared to angiotensin converting enzyme inhibition in conscious dogs with pacing-induced heart failure Cardiovasc Res, June 1, 1997; 34(3): 464 - 472. [Abstract] [Full Text] [PDF]

				S. Teramura, T. Yamakado, M. Maeda, and T. Nakano Effects of MCI-154, a Calcium Sensitizer, on Left Ventricular Systolic and Diastolic Function in Pacing-Induced Heart Failure in the Dog Circulation, February 4, 1997; 95(3): 732 - 739. [Abstract] [Full Text]

				Y. Fu, D. W O'Brien, S. Y Chan, S. Kaufman, G. W Moe, and P. W Armstrong Does a hypertonic saline load predict fluid retention in pacing induced heart failure? Cardiovasc Res, January 1, 1997; 33(1): 172 - 180. [Abstract] [Full Text] [PDF]

				S. Kaab, H. B. Nuss, N. Chiamvimonvat, B. O'Rourke, P. H. Pak, D. A. Kass, E. Marban, and G. F. Tomaselli Ionic Mechanism of Action Potential Prolongation in Ventricular Myocytes From Dogs With Pacing-Induced Heart Failure Circ. Res., February 1, 1996; 78(2): 262 - 273. [Abstract] [Full Text]

				F. H. H. Leenen, B. S. Huang, H. Yu, and B. Yuan Brain `Ouabain' Mediates Sympathetic Hyperactivity in Congestive Heart Failure Circ. Res., November 1, 1995; 77(5): 993 - 1000. [Abstract] [Full Text]

				G. M. Eaton, R. J. Cody, E. Nunziata, and P. F. Binkley Early Left Ventricular Dysfunction Elicits Activation of Sympathetic Drive and Attenuation of Parasympathetic Tone in the Paced Canine Model of Congestive Heart Failure Circulation, August 1, 1995; 92(3): 555 - 561. [Abstract] [Full Text]

				F. G. Spinale, H. H. Holzgrefe, R. Mukherjee, R. B. Hird, J. D. Walker, A. Arnim-Barker, J. R. Powell, and W. H. Koster Angiotensin-Converting Enzyme Inhibition and the Progression of Congestive Cardiomyopathy : Effects on Left Ventricular and Myocyte Structure and Function Circulation, August 1, 1995; 92(3): 562 - 578. [Abstract] [Full Text]

				M. R. Wolff, L. F. Whitesell, and R. L. Moss Calcium Sensitivity of Isometric Tension Is Increased in Canine Experimental Heart Failure Circ. Res., May 1, 1995; 76(5): 781 - 789. [Abstract] [Full Text]

				D. Atar, P. H. Backx, M. M. Appel, W. D. Gao, and E. Marban Excitation-Transcription Coupling Mediated by Zinc Influx through Voltage-dependent Calcium Channels J. Biol. Chem., February 10, 1995; 270(6): 2473 - 2477. [Abstract] [Full Text] [PDF]